Αποτελέσματα Αναζήτησης
1 Σεπ 2022 · IgD myeloma was historically associated with worse outcomes, but we now report a standard cytogenetic risk profile and survival outcomes. Improved IgD myeloma survival is due to earlier diagnosis, improved supportive care, and response to novel antimyeloma therapies.
In two patients, the clinical symptoms of HIDS preceded the rise in serum IgD, indicating that elevated IgD concentration is not the cause of the clinical symptoms in this syndrome . HIDS is probably inherited as an autosomal recessive trait ( 33 ).
1 Αυγ 2024 · Cancerous plasma cells produce abnormal antibody proteins that can be found with blood and urine tests. The most common antibody associated with multiple myeloma is immunoglobulin G (IgG), and immunoglobulin A (IgA) is the second most common.
17 Ιουλ 2019 · Objective: Immunoglobulin D (IgD) levels are often elevated in patients with autoimmune diseases. However, the oncogenic activities of IgD and IgD receptor (IgDR) in diffuse large B-cell lymphoma (DLBCL) have not been reported in detail.
Definition and Introduction. Multiple Myeloma (also known as Myeloma or Plasma Cell Myeloma) is a malignancy of plasma cells, which are the white blood cells responsible for the production of antibodies (proteins). Antibodies protect humans from infections.
A monoclonal IgD protein is present in 1% of patients with myeloma. Monoclonal IgD proteins are often in low concentrations and do not have a quantifiable monoclonal protein on serum protein electrophoresis. However, the presence of an IgD monoclonal protein is almost always indicative of a malignant plasma cell disorder such as multiple
23 Ιαν 2024 · Hyperimmunoglobulin D syndrome (HIDS; MIM #260920) is a rare, autosomal recessive genetic disorder characterized by recurrent febrile episodes typically associated with lymphadenopathy, abdominal pain, and an elevated serum polyclonal immunoglobulin D (IgD) level.
